Lipoxygenase inhibiting compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514555, 562621, 562623, 562874, 260545R, C07C 8310, A61K 31185, A61K 31085, A61K 3113

Patent

active

048974226

ABSTRACT:
Compounds of the formula: ##STR1## where R.sub.1 is amino or methyl; R.sub.2 is C.sub.1 -C.sub.2 alkyl; R.sub.3 is one or more substituents selected from hydrogen, halogen or trihalomethyl; R.sub.4 is one or more substituents selected from hydrogen, halogen, trihalomethyl, C.sub.1 to C.sub.4 alkoxy or C.sub.1 to C.sub.4 alkyl; and M is hydrogen, a pharmaceutically acceptable cation, aroyl, or C.sub.1 to C.sub.6 alkoyl are inhibitors of 5- and/or 12-lipoxygenase enzymes.

REFERENCES:
patent: 3855242 (1984-12-01), Chapman et al.
patent: 3890377 (1975-06-01), Marshall
patent: 3928384 (1975-12-01), Descamps et al.
patent: 4604407 (1986-08-01), Haslanger et al.
patent: 4738986 (1988-04-01), Kneen et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Lipoxygenase inhibiting compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lipoxygenase inhibiting compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipoxygenase inhibiting compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1923804

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.